To explore the association between signal transducer and activator of transcription 3 (STAT3) expression, tumor immune microenvironment, and overall survival (OS) in breast cancer, and to develop a non-invasive radiomics model for early risk stratification using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). This evidence concerns the gene STAT3 and breast cancer.